Nancy Crotti

And the XPRIZE Goes to . . .

Posted in by Nancy Crotti on April 25, 2017
A Pennsylvania-based team invented a diagnostic tool inspired by Star Trek and landed millions of dollars to bring it to market. Nancy CrottiFinal Frontier Medical Devices won the Qualcomm Tricorder XPRIZE for its DxtER prototype device. A family of engineers and doctors has taken their co... Continue

Electric Field Treatment May Boost Pancreatic Cancer Survival Rates

Posted in by Nancy Crotti on April 13, 2017
A European study of Novocure's tumor-treating fields technology yielded encouraging results for patients with a deadly cancer.Nancy Crotti  A recent small study of low-intensity, alternating electric fields in treating pancreatic cancer suggests longer survival times.Novocure (St. Helier, ... Continue

Five Years Out, Prostate Procedure Bears Little Repeating

Posted in by Nancy Crotti on April 3, 2017
Data from NeoTract Inc.'s pivotal trial show UroLift reduces symptoms, and is well tolerated.Nancy CrottiNeoTract Inc.'s UroLift system consists of permanent implants designed to retract the lateral lobes of the prostate gland to reduce compression of the urethra. The procedure does not require cutt... Continue

Breath Biopsy Company Lands Major Insurer’s Investment

Posted in by Nancy Crotti on March 31, 2017
Owlstone Medical will use new funding to commercialize its early-detection technology.Nancy CrottiOwlstone Medical's FAIMS platform is designed to detect disease biomarkers in breath. A British company developing “breath biopsy” technology to detect early-stage cancer has landed an investme... Continue

Bos Sci Strikes $435M Deal for Swiss TAVR Player

Posted by Nancy Crotti on March 30, 2017
Boston Scientific's plan to buy Symetis is seen as complementary to the company’s embattled structural heart line.Nancy Crotti Boston Scientific plans to buy a Swiss transcatheter aortic valve replacement (TAVR) company for $435 million in cash. The purchase of Symetis will complement its str... Continue

Two Canadian Medtech Companies Combine to Boost U.S. Presence

Posted in by Nancy Crotti on March 28, 2017
StarFish Medical and Kangaroo Group complement each other well, according to StarFish’s CEO.Nancy CrottiA fast-growing company in western Canada is buying a smaller company in Toronto to form the country’s largest medtech design and development firm.StarFish Medical of Victoria, BC, expects... Continue

Bos Sci's Synergy Stent Beats Promus on Safety

Posted in by Nancy Crotti on March 23, 2017
Study shows Boston Scientific's bioabsorbable-polymer drug-eluting stent yields fewer blood clots than its Promus stent. Nancy Crotti EVOLVE II data showed Boston Scientific's Synergy bioabsorbable-polymer-coated drug-eluting stent is safer than the company's Promus Element Plus stent, whi... Continue

How a pH Indicator Made Blood Typing Faster, Cheaper

Posted in by Nancy Crotti on March 17, 2017
Chinese researchers believe their new, paper-based test could be used in war zones and remote locationsNancy Crotti Chinese researchers have developed a speedy paper blood-type test using a common pH indicator.The researchers used antibodies immobilized on paper test strips to separate red bloo... Continue

Total-body PET, Find Out What it Means to Thee

Posted in by Nancy Crotti on March 16, 2017
Researchers have NIH funding and industry partners for a total-body PET machine that could work faster and produce better images. Nancy Crotti U.S. and British researchers are closing in on creating a total-body positron emission tomography (PET) scanner that would work faster and with les... Continue

FDA Approves Stent for Troublesome Cardiac Artery Lesions

Posted in by Nancy Crotti on March 9, 2017
The Tryton side-branch stent is compatible with stents manufactured to treat lesions in the main coronary artery, according to its North Carolina manufacturer.Nancy CrottiTryton Medical's side-branch stent is designed to treat, protect, and secure bifurcation lesions and integrates into any conventi... Continue